Diagnostic Services

Featured Image

DNA Damage Response Deficiency (DDRD) in Breast Cancer is associated with a STING-dependent Innate Immune Response

This may provide a therapeutic rationale for immune-checkpoint targeted therapies in the context of DNA damage response deficiency in cancer.

Read Poster
Featured Image

Illumina TruSight Oncology 500 ctDNA Liquid Biopsy Panel: Application within Almac Diagnostic Services Laboratory

In this webinar presentation, recorded with kind permission from Illumina at their recent Comprehensive Genomic Profiling (CGP) event, hear from Killian McSorley, Assay Validation and Development Manager at Almac Diagnostic Services.

View Webinar

Make an Enquiry

If you are interested in our Diagnostic Services, then please contact us
Contact Us

Meet the Experts

Learn more about our experts in your discipline today
Find out More
This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies